Annual Total Long Term Liabilities
$13.33 M
-$2.15 M-13.88%
31 December 2023
Summary:
Intra-Cellular Therapies annual total long term liabilities is currently $13.33 million, with the most recent change of -$2.15 million (-13.88%) on 31 December 2023. During the last 3 years, it has fallen by -$10.27 million (-43.53%). ITCI annual total long term liabilities is now -43.53% below its all-time high of $23.60 million, reached on 31 December 2020.ITCI Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$13.51 M
-$611.00 K-4.33%
30 September 2024
Summary:
Intra-Cellular Therapies quarterly total long term liabilities is currently $13.51 million, with the most recent change of -$611.00 thousand (-4.33%) on 30 September 2024. Over the past year, it has dropped by -$385.00 thousand (-2.77%). ITCI quarterly long term liabilities is now -43.42% below its all-time high of $23.87 million, reached on 30 September 2020.ITCI Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ITCI Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.9% | -2.8% |
| 3 y3 years | -43.5% | -33.5% |
| 5 y5 years | +317.4% | -33.4% |
ITCI Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -43.5% | at low | -33.5% | +6.0% |
| 5 y | 5 years | -43.5% | +317.4% | -43.4% | +6.0% |
| alltime | all time | -43.5% | -43.4% |
Intra-Cellular Therapies Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $13.51 M(-4.3%) |
| June 2024 | - | $14.12 M(+10.8%) |
| Mar 2024 | - | $12.74 M(-4.4%) |
| Dec 2023 | $13.33 M(-13.9%) | $13.33 M(-4.1%) |
| Sept 2023 | - | $13.89 M(-3.7%) |
| June 2023 | - | $14.43 M(-3.5%) |
| Mar 2023 | - | $14.96 M(-3.3%) |
| Dec 2022 | $15.47 M(-17.1%) | $15.47 M(-19.3%) |
| Sept 2022 | - | $19.17 M(+0.5%) |
| June 2022 | - | $19.07 M(+13.8%) |
| Mar 2022 | - | $16.76 M(-10.3%) |
| Dec 2021 | $18.68 M(-20.9%) | $18.68 M(-8.1%) |
| Sept 2021 | - | $20.32 M(-6.3%) |
| June 2021 | - | $21.69 M(-4.2%) |
| Mar 2021 | - | $22.64 M(-4.1%) |
| Dec 2020 | $23.60 M(+18.3%) | $23.60 M(-1.1%) |
| Sept 2020 | - | $23.87 M(+12.8%) |
| June 2020 | - | $21.16 M(+7.3%) |
| Mar 2020 | - | $19.72 M(-1.2%) |
| Dec 2019 | $19.96 M(+525.1%) | $19.96 M(-1.6%) |
| Sept 2019 | - | $20.27 M(-1.4%) |
| June 2019 | - | $20.57 M(-1.4%) |
| Mar 2019 | - | $20.86 M(+553.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $3.19 M(+12.4%) | $3.19 M(+12.7%) |
| Sept 2018 | - | $2.83 M(+3.0%) |
| June 2018 | - | $2.75 M(-1.7%) |
| Mar 2018 | - | $2.80 M(-1.5%) |
| Dec 2017 | $2.84 M(-1.0%) | $2.84 M(-1.2%) |
| Sept 2017 | - | $2.88 M(-1.2%) |
| June 2017 | - | $2.91 M(-1.2%) |
| Mar 2017 | - | $2.95 M(+2.7%) |
| Dec 2016 | $2.87 M(+79.6%) | $2.87 M(+11.9%) |
| Sept 2016 | - | $2.56 M(+13.5%) |
| June 2016 | - | $2.26 M(+14.6%) |
| Mar 2016 | - | $1.97 M(+23.4%) |
| Dec 2015 | $1.60 M(>+9900.0%) | $1.60 M(+81.3%) |
| Sept 2015 | - | $881.10 K(+69.2%) |
| June 2015 | - | $520.60 K(+225.2%) |
| Mar 2015 | - | $160.10 K(>+9900.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2014 | - | $0.00(0.0%) |
| June 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2013 | - | $0.00(0.0%) |
| June 2013 | - | $0.00 |
| Mar 2013 | $0.00 | - |
FAQ
- What is Intra-Cellular Therapies annual total long term liabilities?
- What is the all time high annual total long term liabilities for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies annual total long term liabilities year-on-year change?
- What is Intra-Cellular Therapies quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies quarterly long term liabilities year-on-year change?
What is Intra-Cellular Therapies annual total long term liabilities?
The current annual total long term liabilities of ITCI is $13.33 M
What is the all time high annual total long term liabilities for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high annual total long term liabilities is $23.60 M
What is Intra-Cellular Therapies annual total long term liabilities year-on-year change?
Over the past year, ITCI annual total long term liabilities has changed by -$2.15 M (-13.88%)
What is Intra-Cellular Therapies quarterly total long term liabilities?
The current quarterly long term liabilities of ITCI is $13.51 M
What is the all time high quarterly long term liabilities for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high quarterly total long term liabilities is $23.87 M
What is Intra-Cellular Therapies quarterly long term liabilities year-on-year change?
Over the past year, ITCI quarterly total long term liabilities has changed by -$385.00 K (-2.77%)